HIGHLIGHTS
- who: Napaporn Chantasrisawad and collaborators from the Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand have published the article: Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases, in the Journal: Vaccines 2022, x of 10/05/2021
- what: The authors aim to describe of mRNA BNT162b2 among adolescents who are immunocompromised or have chronic diseases. The strengths of this study are that the authors focused on adolescents with chronic diseases and a wide variety of immunocompromised participants, e_g, kidney transplantation, HSCT, cancer, and autoimmune disorders, who . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.